Liferol

Formoterol Fumarate Dihydrate, the active ingredient in Liferol, is a long‑acting β2‑adrenergic agonist (LABA) presented as an inhalation product for inhalation use. It provides sustained bronchodilation to help manage asthma and chronic obstructive pulmonary disease (COPD) in adult patients, improving airflow and reducing symptom frequency.

GNH USA supplies Liferol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows European Union manufacturing standards, provides full regulatory documentation, and offers reliable global logistics for bulk and parcel orders.

Formoterol is a long‑acting β2‑adrenergic agonist used in maintenance therapy for obstructive airway diseases.

- Asthma (maintenance therapy): improves airway patency, reduces frequency of symptoms and exacerbations. - Chronic obstructive pulmonary disease (COPD): enhances lung function, decreases rescue medication use and lowers risk of exacerbations. - Exercise‑induced bronchoconstriction (prevention): provides sustained bronchodilation to help prevent airway narrowing during physical activity.

Formoterol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Tremor: mild muscle shaking, often transient. - Headache: dull or throbbing head pain. - Throat irritation: discomfort or soreness in the throat. - Cough: transient cough after inhalation.

Serious or Rare Side Effects: - Paradoxical bronchospasm: sudden worsening of breathing requiring immediate medical attention. - Cardiac arrhythmias: irregular heartbeats, palpitations, or tachycardia. - Hypersensitivity reactions: rash, angioedema, or anaphylaxis. - Low potassium (hypokalemia): may occur especially with concomitant diuretics.

When prescribing or dispensing Formoterol, several safety considerations should be observed. - Dose titration: follow the prescriber’s instructions and adjust based on clinical response. - Monitor lung function: assess spirometry or peak flow regularly to ensure efficacy. - Avoid monotherapy for acute relief: do not use Formoterol alone as a rescue inhaler. - Cardiovascular caution: use carefully in patients with arrhythmias, hypertension, or coronary disease. - Pregnancy and lactation: risk category unknown; discuss potential benefits and risks with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Formoterol can interact with other medicines, influencing its bronchodilator effect or increasing adverse event risk.

Major Interactions (Avoid): - Beta‑blockers: may antagonize bronchodilation and precipitate bronchospasm. - MAO inhibitors: can enhance cardiovascular stimulation, raising the risk of tachycardia.

Moderate Interactions (Monitor Closely): - Diuretics: may increase the likelihood of hypokalemia when combined with Formoterol. - Theophylline: concurrent use can raise the chance of tremor and tachycardia. - Other LABAs or long‑acting bronchodilators: additive effects may increase risk of cardiovascular side effects.